Optimax Employees
Prof Dr Bertram Häussler

Prof Dr. Bertram Häussler (Ph.D.) is head of the iGES group He is an honorary professor at the Technical University of Berlin in "Economics of the Pharmaceutical Industry His scientific focus is on industrial economics, health economics, health care research, benefit assessment, and drug development

Dr Amir Ansaripour
Associate Director

Dr Amir Ansaripour (Ph.D.) is a health economist. He has collaborated with pharma companies from different countries in cost-effectiveness analyses of new technologies for various diseases.
His Ph.D. research focused on cost-effectiveness analyses, modeling, and reimbursement policy analysis. During past years, he has applied various methods such as questionnaire/survey analysis, data mining on a large claims database, real-world cost analysis, Markov modeling, pharmaceutical pricing, and market access strategy in his projects.

Dr Mehdi Javanbakht
Chief Executive Officer

Mehdi holds a Ph.D. in Health Economics and has over 14 years of experience in academia and industry. He used to work as an ERG member for NICE. Mehdi has built over 80 economic evaluation models from scratch for different diseases (Cancer, diabetes, cardiovascular diseases, Ophthalmology, ...) and has over 120 publications in high impact journals. He has a strong commercial sense and in-depth knowledge of modeling.

Atefeh Mashayekhi
Head of Evidence Synthesis Team

Atefeh was an Evidence Synthesis Analyst at NIHR Innovation Observatory. She was also a member of the Evidence Synthesis and Health Economics Teams in the Institute of Health & Society. She has a strong background in health economics and Evidence Synthesis. She has published several Cochrane systematic reviews.

Eoin Moloney

Senior Health Economist

Eoin Moloney (MSc) is a senior health economist, with over eight years’ experience in academia and industry. He has worked across a wide range of clinical disease areas, focussing on the cost-effectiveness and budget-impact of a variety of medical and pharmaceutical interventions. He has a strong track record of publications in high-impact clinical and economic journals, and an in-depth understanding of the methods required to demonstrate the cost-effectiveness of new technologies.

Our independent cooperation partners
Professor Maziar Moradi-Lakeh
Head of Clinical Research Team

Maziar is a Medical Doctor with post-graduate studies in health metric and evaluation. He has been a consultant for several international organizations, governments, and companies. Maziar has contributed to publishing more than 180 papers in peer-reviewed journals.

Dr Mohsen Yaghoubi
Senior Health Economics Scientist

Mohsen holds a PhD in health economics with several years of experience in academia and industry. He has built several economic evaluation models in different diseases area.

Dr Maryam Saeedi
Senior Clinical Scientist

Maryam is a doctor of medicine, she has more than 8 years of experience in the pharmaceutical industry. She also has worked in the medical device and medical insurance field. Her area of expertise in pharmaceutical is mostly in medical, sales and R&D departments.

Mrs Neda Shahbandian
Financial Manger

Neda holds Masters of Science (MScs) in accounting with over 12 years of experience in multiple companies as a financial manager and senior accountant. Neda has extensive experience in preparing and analyzing financial statements.